Literature DB >> 1317469

Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum.

P A Bush1, W J Aronson, G M Buga, J Rajfer, L J Ignarro.   

Abstract

Nitric oxide (NO) caused a potent, marked, and transient relaxation of precontracted strips of corpus cavernosum isolated from humans and rabbits. The relaxation response elicited by NO was very similar to the relaxation evoked by electrical field stimulation via the nonadrenergic-noncholinergic pathway. Sodium nitroprusside, nitroglycerin, and S-nitroso-N-acetylpenicillamine, which are nitrovasodilators known to generate NO, also caused marked concentration-dependent relaxation of corpus cavernosum. Relaxant responses to NO were enhanced by the cyclic GMP phosphodiesterase inhibitor M&B 22,948 and inhibited by oxyhemoglobin. Similarly, relaxation of corpus cavernosum in response to electrical field stimulation or acetylcholine was enhanced by M&B 22,948 and inhibited by oxyhemoglobin. NO stimulated cyclic GMP formation in corpus cavernosum and a close positive correlation was found between the magnitudes of relaxation and cyclic GMP formation. The data suggest that NO-elicited activation of guanylate cyclase and cyclic GMP formation represents the signal transduction mechanism responsible for relaxation and nonadrenergic-noncholinergic-mediated penile erection. These observations indicate that NO is a potent relaxant of human and rabbit corpus cavernosum and support our hypothesis that endogenous NO is the principal mediator of penile erection caused by nonadrenergic-noncholinergic stimulation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1317469     DOI: 10.1016/s0022-5347(17)37671-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  24 in total

Review 1.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

2.  Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.

Authors:  K Hallén; N P Wiklund; L E Gustafsson
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 3.  Regulation of tone in penile cavernous smooth muscle. Established concepts and new findings.

Authors:  K E Andersson; F Holmquist
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

4.  Inhaled sildenafil as an alternative to oral sildenafil in the treatment of pulmonary arterial hypertension (PAH).

Authors:  Jahidur Rashid; Brijeshkumar Patel; Eva Nozik-Grayck; Ivan F McMurtry; Kurt R Stenmark; Fakhrul Ahsan
Journal:  J Control Release       Date:  2017-02-07       Impact factor: 9.776

5.  Adrenomedullin and nitric oxide in children with detrusor instability.

Authors:  Ayşe Balat; Kemal Sarica; Mustafa Cekmen; Muhittin Yürekli; Faruk Yağci; Ahmet Erbağci
Journal:  Pediatr Nephrol       Date:  2003-04-08       Impact factor: 3.714

6.  Gene transfer of endothelial nitric oxide synthase to the penis augments erectile responses in the aged rat.

Authors:  H C Champion; T J Bivalacqua; A L Hyman; L J Ignarro; W J Hellstrom; P J Kadowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

7.  Selective nitrergic neurodegeneration in diabetes mellitus - a nitric oxide-dependent phenomenon.

Authors:  S Cellek; J Rodrigo; E Lobos; P Fernández; J Serrano; S Moncada
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

8.  Impairment of endothelium- and nerve-mediated relaxation responses in the cavernosal smooth muscle of experimentally diabetic rabbits: role of weight loss and duration of diabetes.

Authors:  Nihan Burul Bozkurt; Can Pekiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-30       Impact factor: 3.000

Review 9.  Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction.

Authors:  Fabiano B Calmasini; Nicole Klee; R Clinton Webb; Fernanda Priviero
Journal:  Sex Med Rev       Date:  2019-07-17

10.  Topical treatment of erectile dysfunction: randomised double blind placebo controlled trial of cream containing aminophylline, isosorbide dinitrate, and co-dergocrine mesylate.

Authors:  A Gomaa; M Shalaby; M Osman; M Eissa; A Eizat; M Mahmoud; N Mikhail
Journal:  BMJ       Date:  1996-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.